SECRETORY MECHANISMS OF GROWTH-HORMONE (GH)-RELEASING PEPTIDE-INDUCED, GH-RELEASING HORMONE-INDUCED, AND THYROTROPIN-RELEASING HORMONE-INDUCED GH RELEASE IN PATIENTS WITH ACROMEGALY
K. Hanew et al., SECRETORY MECHANISMS OF GROWTH-HORMONE (GH)-RELEASING PEPTIDE-INDUCED, GH-RELEASING HORMONE-INDUCED, AND THYROTROPIN-RELEASING HORMONE-INDUCED GH RELEASE IN PATIENTS WITH ACROMEGALY, The Journal of clinical endocrinology and metabolism, 83(10), 1998, pp. 3578-3583
The: GH secretory mechanism of GH-releasing hexapeptide (GHRP-6), GHRH
, and TRH were studied in vivo and in vitro in seven patients with acr
omegaly. In an in vivo study, these patients showed clear GH responses
to single administration of GHRP (four of four patients), GHRH (seven
of seven patients), and TRH (seven of seven patients) and enhanced re
sponses to GHRP plus GHRH (two of four patients) or TRH plus GHRH (six
of six patients). In an in vitro dispersed cell study, the majority o
f patients examined also showed clear GH responses to GHRP (four of fo
ur patients), GHRH (six of six patients), and TRH (four of four patien
ts) and an enhanced response to GHRF plus GHRH (three of three patient
s) or TRH plus GHRH (three of four patients). In one patient (no. 3).
GHRP plus forskolin (adenylate cyclase activator), but not GHRP plus p
horbol 12-myristate 13-acetate (protein kinase C activator), additivel
y enhanced the GH response. Nordihydroguaiaretic acid (NDGA; inhibitor
of arachidonic cascade) inhibited GH release induced by GHRP, TRH, GH
RH, TRH plus GHRH. or GHRP plus GHRH, but did not inhibit basal GH sec
retion. In contrast, NDGA distinctly elevated intracellular cAMP level
s in another patient (no. 7) when coadministered with GHRP, GHRH, or G
HRP plus GHRH, whereas cAMP lei els mere not modified by single admini
stration of GHRP and NDGA. The GH response to the combined administrat
ion of GHRP and GHRH was synergistic in this patient, but was additive
in the other two patients. It is concluded that GHRF, TRH, and GHRH d
irectly stimulate in vivo and in vitro GR release from human somatotrp
inomas, and GHRP and TRH mainly exert their action through activation
of the phosphatidylinositol-protein kinase C pathway, whereas GHRH exe
rts its action through the adenylate cyclase-protein kinase A pathway.
These three agents seem to release GH sia the arachidonic cascade.